Ownership history in Clean Yield Group · 17 quarters on record
This page tracks every 13F SEC filing in which Clean Yield Group reported a position in TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS (TAK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 260,804 | -5,234 | -2.0% | 1.13% | $4.1M | $15.59 |
| 2025 Q3 | REDUCED | 266,038 | -8,978 | -3.3% | 1.10% | $3.9M | $14.64 |
| 2025 Q2 | REDUCED | 275,016 | -11,540 | -4.0% | 1.27% | $4.3M | $15.46 |
| 2025 Q1 | REDUCED | 286,556 | -73,535 | -20.4% | 1.39% | $4.3M | $14.87 |
| 2024 Q4 | REDUCED | 360,091 | -46,137 | -11.4% | 1.52% | $4.8M | $12.94 |
| 2024 Q3 | REDUCED | 406,228 | -38,912 | -8.7% | 1.83% | $5.8M | $13.90 |
| 2024 Q2 | REDUCED | 445,140 | -36,312 | -7.5% | 2.15% | $5.8M | $12.36 |
| 2024 Q1 | REDUCED | 481,452 | -29,070 | -5.7% | 2.60% | $6.7M | $13.27 |
| 2023 Q4 | REDUCED | 510,522 | -22,635 | -4.2% | 3.07% | $7.3M | $13.36 |
| 2023 Q3 | REDUCED | 533,157 | -10,885 | -2.0% | 3.62% | $8.2M | $14.48 |
As of 2025 Q4 — sorted by position size